Andrews Ronald Asbury reported grant involving 92,858 derivative units of CERENOME, INC. at $0.00 for $0 on Nov 9, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Chief Business Officer
Chief Business Officer
Filed Nov 12, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
92,858Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
92,858Direct
Trade date
Nov 9, 2026Grant
Filed
Nov 12, 2026, 8:30 AM ET3-day reporting delay
Accession
0001193125-26-457094Code A · Transaction 398248
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

CNSY price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CNSY · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +14%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: The options vest in forty-eight (48) monthly installments as follows: (i) fifty percent (50%) of the shares subject to the Option will vest in twelve (12) equal monthly installments during the first twelve (12) months following the Grant Date, beginning on the one-month anniversary of the Grant Date; and (ii) the remaining fifty percent (50%) of the shares subject to the Option will vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.